A Randomized Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Subjects With Hypertrophic Scar
Status:
Terminated
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, within-subject placebo controlled study to evaluate the
safety and efficacy of various doses of STP705 administered as intradermal Injection in
subjects with hypertrophic scar. The goals are to determine the recommended Phase 2 dose, the
pharmacokinetics and pharmacidynamics parameters, and conduct analysis of biomarkers common
to the scar formation pathway.